[{"address1": "601 Brickell Key Drive", "address2": "Suite 1000", "city": "Miami", "state": "FL", "zip": "33131", "country": "United States", "phone": "305 203 2034", "website": "https://www.smmttx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Summit Therapeutics Inc., a biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies. Its lead development candidate is ivonescimab, a bispecific antibody for immunotherapy through blockade of PD-1 with the anti-angiogenesis, as well as in Phase III clinical trials for the treatment of non-small lung cancer. The company was founded in 2003 and is headquartered in Miami, Florida.", "fullTimeEmployees": 159, "companyOfficers": [{"maxAge": 1, "name": "Mr. Robert W. Duggan", "age": 80, "title": "Co-CEO & Executive Chairman", "yearBorn": 1944, "fiscalYear": 2024, "totalPay": 158613, "exercisedValue": 0, "unexercisedValue": 1133457}, {"maxAge": 1, "name": "Dr. Mahkam  Zanganeh D.D.S., M.B.A.", "age": 54, "title": "Co-CEO, President & Director", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 1161021, "exercisedValue": 0, "unexercisedValue": 128563160}, {"maxAge": 1, "name": "Prof. Dame Kay Davies DBE, FRS CBE", "age": 73, "title": "Co-Founder, Chairman of Scientific Advisory Board and Scientific Advisor", "yearBorn": 1951, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Bhaskar  Anand", "age": 47, "title": "Chief Accounting Officer", "yearBorn": 1977, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Nathan  LiaBraaten", "title": "Senior Director of Investor Relations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Dave  Gancarz", "title": "Chief Business & Strategy Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Fong  Clow", "title": "Chief Biometrics Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Urte  Gayko Ph.D.", "age": 53, "title": "Chief Regulatory, Quality & Pharmacovigilance Officer", "yearBorn": 1971, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Allen S. Yang M.D., Ph.D.", "age": 56, "title": "Head of R&D Strategy", "yearBorn": 1968, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Laura Q. M. Chow M.D.", "title": "Senior Vice President of Clinical Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 4, "boardRisk": 10, "compensationRisk": 10, "shareHolderRightsRisk": 5, "overallRisk": 10, "governanceEpochDate": 1761955200, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 18.45, "open": 18.02, "dayLow": 17.55, "dayHigh": 18.31, "regularMarketPreviousClose": 18.45, "regularMarketOpen": 18.02, "regularMarketDayLow": 17.55, "regularMarketDayHigh": 18.31, "payoutRatio": 0.0, "beta": -1.547, "forwardPE": -47.842106, "volume": 2681655, "regularMarketVolume": 2681655, "averageVolume": 4148881, "averageVolume10days": 2905020, "averageDailyVolume10Day": 2905020, "bid": 18.12, "ask": 18.23, "bidSize": 7, "askSize": 4, "marketCap": 13533966336, "fiftyTwoWeekLow": 15.55, "fiftyTwoWeekHigh": 36.91, "allTimeHigh": 36.91, "allTimeLow": 0.66, "fiftyDayAverage": 20.3086, "twoHundredDayAverage": 22.331224, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 13300839424, "profitMargins": 0.0, "floatShares": 102546960, "sharesOutstanding": 744442538, "sharesShort": 32272331, "sharesShortPriorMonth": 32214253, "sharesShortPreviousMonthDate": 1757894400, "dateShortInterest": 1760486400, "sharesPercentSharesOut": 0.0434, "heldPercentInsiders": 0.86053, "heldPercentInstitutions": 0.13933, "shortRatio": 8.5, "shortPercentOfFloat": 0.2725, "impliedSharesOutstanding": 744442538, "bookValue": 0.258, "priceToBook": 70.46512, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -921617024, "trailingEps": -1.25, "forwardEps": -0.38, "enterpriseToEbitda": -14.226, "52WeekChange": -0.16490585, "SandP52WeekChange": 0.12121439, "quoteType": "EQUITY", "currentPrice": 18.18, "targetHighPrice": 41.173683, "targetLowPrice": 11.776319, "targetMeanPrice": 31.528515, "targetMedianPrice": 35.071007, "recommendationMean": 1.66667, "recommendationKey": "buy", "numberOfAnalystOpinions": 13, "totalCash": 238554000, "totalCashPerShare": 0.32, "ebitda": -934987008, "totalDebt": 5428000, "quickRatio": 3.674, "currentRatio": 3.796, "debtToEquity": 2.823, "returnOnAssets": -1.5288, "returnOnEquity": -2.92492, "freeCashflow": 73795752, "operatingCashflow": -269664992, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "SMMT", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "earningsTimestamp": 1760963400, "earningsTimestampStart": 1760963400, "earningsTimestampEnd": 1760963400, "earningsCallTimestampStart": 1746131400, "earningsCallTimestampEnd": 1746131400, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -1.25, "epsForward": -0.38, "epsCurrentYear": -0.81536, "priceEpsCurrentYear": -22.2969, "cryptoTradeable": false, "marketState": "CLOSED", "shortName": "Summit Therapeutics Inc.", "longName": "Summit Therapeutics Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1425565800000, "postMarketChangePercent": 0.6600601, "postMarketPrice": 18.3, "postMarketChange": 0.11999893, "regularMarketChange": -0.27, "regularMarketDayRange": "17.55 - 18.31", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 4148881, "fiftyTwoWeekLowChange": 2.63, "fiftyTwoWeekLowChangePercent": 0.16913185, "fiftyTwoWeekRange": "15.55 - 36.91", "fiftyTwoWeekHighChange": -18.73, "fiftyTwoWeekHighChangePercent": -0.5074505, "fiftyTwoWeekChangePercent": -16.490585, "fiftyDayAverageChange": -2.1285992, "fiftyDayAverageChangePercent": -0.104812704, "twoHundredDayAverageChange": -4.151224, "twoHundredDayAverageChangePercent": -0.18589327, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "prevName": "Summit Therapeutics plc", "nameChangeDate": "2025-11-07", "averageAnalystRating": "1.7 - Buy", "regularMarketChangePercent": -1.46342, "regularMarketPrice": 18.18, "corporateActions": [], "postMarketTime": 1762561170, "regularMarketTime": 1762549200, "exchange": "NGM", "messageBoardId": "finmb_11611587", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "displayName": "Summit Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-11-08"}]